FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Graham Maw

Research Profile

Concepts & Ideas

Living Beings

Dogs
Rats

Chemicals & Drugs

Co-author Network

Publications

TOP 3
David C Pryde; Graham N Maw; Simon Planken; Michelle Y Platts; Vivienne Sanderson; Martin Corless; Alan Stobie; Christopher G Barber; Rachel Russell; Laura Foster; Laura Barker; Christopher Wayman; Piet Van Der Graaf; Peter Stacey; Debbie Morren; Christopher Kohl; Kevin Beaumont; Sara Coggon; Michael Tute
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.
Charlotte M N Allerton; Christopher G Barber; Kevin Beaumont; David G Brown; Susan M Cole; David Ellis; Charlotte A L Lane; Graham N Maw; Natalie M Mount; David J Rawson; Colin M Robinson; Stephen D A Street; Nicholas W Summerhill
A novel series of potent and selective PDE5 inhibitors with potential for high and dose-independent oral bioavailability.
Donald S Middleton; Graham N Maw; Clare Challenger; Alan Jessiman; Patrick S Johnson; William A Million; Carly L Nichols; Jenny A Price; Michael Trevethick
Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Graham Maw (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: David C Pryde; Graham N Maw; Simon Planken; Michelle Y Platts; Vivienne Sanderson; Martin Corless; Alan Stobie; Christopher G Barber; Rachel Russell; Laura Foster; Laura Barker; Christopher Wayman; Piet Van Der Graaf; Peter Stacey; Debbie Morren; Christopher Kohl; Kevin Beaumont; Sara Coggon; Michael Tute
Novel selective inhibitors of neutral endopeptidase for the treatment of female sexual arousal disorder. Synthesis and activity of functionalized glutaramides.
Journal of medicinal chemistry 2006;49(14):4409-24.
2006: Charlotte M N Allerton; Christopher G Barber; Kevin Beaumont; David G Brown; Susan M Cole; David Ellis; Charlotte A L Lane; Graham N Maw; Natalie M Mount; David J Rawson; Colin M Robinson; Stephen D A Street; Nicholas W Summerhill
A novel series of potent and selective PDE5 inhibitors with potential for high and dose-independent oral bioavailability.
Journal of medicinal chemistry 2006;49(12):3581-94.
2006: Donald S Middleton; Graham N Maw; Clare Challenger; Alan Jessiman; Patrick S Johnson; William A Million; Carly L Nichols; Jenny A Price; Michael Trevethick
Highly potent and selective zwitterionic agonists of the delta-opioid receptor. Part 1.
Bioorganic & medicinal chemistry letters 2006;16(4):905-10.
2006: Graham N Maw; Alan Stobie; Simon Planken; David C Pryde; Vivienne Sanderson; Michelle Y Platts; Martin Corless; Peter Stacey; Christopher Wayman; Piet Van Der Graaf; Christopher Kohl; Sara Coggon; Kevin Beaumont
The discovery of small molecule inhibitors of neutral endopeptidase. Structure-activity studies on functionalized glutaramides.
Chemical biology & drug design 2006;67(1):74-7.
2003: Graham N Maw; Charlotte M N Allerton; Eugene Gbekor; William A Million
Design, synthesis and biological activity of beta-carboline-based type-5 phosphodiesterase inhibitors.
Bioorganic & medicinal chemistry letters 2003;13(8):1425-8.